Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation

Abstract

Pulmonary infiltrates frequently complicate hematopoietic SCT (HSCT). The utility of fiberoptic bronchoscopy (FOB) with bronchoalveolar lavage (BAL) in the evaluation of new pulmonary infiltrates, particularly as it relates to optimal timing of the procedure, is unclear. Based on this, we retrospectively reviewed 501 consecutive, adult, nonintubated patients who underwent 598 BALs for evaluation of new pulmonary infiltrates during the first 100 days following HSCT to determine whether diagnostic yields for infection, subsequent antimicrobial treatment modifications and patient outcomes differed following early vs late referrals for the procedure. The overall yield of BAL for clinically significant pathogens was 55%. Notably, the yield was 2.5-fold higher among FOBs performed within the first 4 days of presentation (early FOB) compared to those performed late, and highest (75%) when performed within 24 h of clinical presentation. Rates of FOB-guided adjustments in antimicrobial therapy (51%) did not differ significantly between early and late examinations. However, late FOB-related antibiotic adjustments were associated with 30-day pulmonary-associated deaths that were threefold higher (6 vs 18%, P=0.0351). Major FOB-related complications occurred in only three (0.6%) patients. We conclude that early referral for FOB in this patient setting is associated with higher diagnostic yields and may favorably impact survival.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Dunagan DA, Baker AM, Hurd DD . Bronchoscopic evaluation of pulmonary infiltrates following bone marrow transplantation. Chest 1997; 111: 135–141.

    Article  CAS  PubMed  Google Scholar 

  2. Rano A, Agussti C, Natividad B, Montserrat R, Andrill J, Pumarola T et al. Prognostic factors of non-HIV immunocompromised patients with pulmonary infiltrates. Chest 2002; 122: 253–261.

    Article  PubMed  Google Scholar 

  3. ATS. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy and preventative strategies. A consensus statement. Am J Respir Crit Care Med 1995; 153: 1711–1725.

    Google Scholar 

  4. Ascioglu S, Rex J, de Pauw B, Bennett J, Bille J, Crokaert F, et al., Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer. Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 1: 7–14.

    Article  Google Scholar 

  5. Prasoon J, Sunder S, Meli Y, Arroiga A, Stoller J, Mehta A . Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest 2004; 125: 712–722.

    Article  Google Scholar 

  6. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH . Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122: 262–268.

    Article  PubMed  Google Scholar 

  7. Kollef M . Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time. Drugs 2003; 63: 2157–2168.

    Article  PubMed  Google Scholar 

  8. Kollef M . Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31 (Suppl 4): S131–S138.

    Article  PubMed  Google Scholar 

  9. Huaringa A . Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients. Bone Marrow Transplant 2000; 25: 975–979.

    Article  CAS  PubMed  Google Scholar 

  10. Glazer M, Breuer R, Berkman N, Lossos IS, Kapelushnik J, Nagler A et al. Use of fiberoptic bronchoscopy in bone marrow transplant recipients. Acta Haematol 1998; 99: 22–26.

    Article  CAS  PubMed  Google Scholar 

  11. Hofmeister CC, Czerlanis C, Forsythe S, Stiff PJ . Retrospective utility of bronchoscopy after hematopoietic stem cell transplant. Bone Marrow Transplant 2006; 38: 693–698.

    Article  CAS  PubMed  Google Scholar 

  12. Hohenadel I, Kiworr M, Genitsariotis R, Zeidler D, Lorenz J . Role of bronchoalveolar lavage in immunocompromised patients with pneumonia treated with a broad spectrum antibiotic and antifungal regimen. Thorax 2001; 56: 115–120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Murray PV, O’Brien ME, Padhani AR, Powles R, Cunningham D, Jeanes A et al. Use of first line bronchoalveolar lavage in the immunosuppressed oncology patient. Bone Marrow Transplant 2001; 27: 967–971.

    Article  CAS  PubMed  Google Scholar 

  14. von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J . Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62: 341–347.

    Article  CAS  PubMed  Google Scholar 

  15. White DA, Wong PW, Downey R . The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 2000; 161 (3 Part 1): 723–729.

    Article  CAS  PubMed  Google Scholar 

  16. White Jr P, Bonacum J, Miller C . Utility of fiberoptic bronchoscopy in bone marrow transplant patients. Bone Marrow Transplant 1997; 20: 681–687.

    Article  CAS  PubMed  Google Scholar 

  17. Guerra L, Baughman R . Use of bronchoalveolar lavage to diagnose bacterial pneumonia in mechanically ventilated patients. Crit Care Med 1990; 18: 169–173.

    Article  CAS  PubMed  Google Scholar 

  18. Haussinger K, Ballin A, Becker HD, Bolcskei P, Dierkesmann R, Dittrich I, et al., Working party on Recommendations for Quality Standards in Endoscopy of the German Society of Pulmonology. Recommendations for quality standards in bronchoscopy. Pneumologie 2004; 58: 344–356.

    Article  CAS  PubMed  Google Scholar 

  19. Wimberley N, Faling L, Bartlett J . A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture. Am Rev Respir Dis 1979; 119: 337–343.

    CAS  PubMed  Google Scholar 

  20. von Eiff M, Zuhlsdorf M, Roos N, Thomas M, Buchner T, van de Loo J . Pulmonary infiltrates in patients with haematologic malignancies: clinical usefulness of non-invasive bronchoscopic procedures. Eur J Haematol 1995; 54: 157–162.

    Article  CAS  PubMed  Google Scholar 

  21. Montravers P, Fagon JY, Chastre J, Lecso M, Dombret MC, Trouillet JL et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 1993; 147: 38–44.

    Article  CAS  PubMed  Google Scholar 

  22. Miller WT, Tino G, Friedburg JS . Thoracic CT in the intensive care unit: assessment of clinical usefulness. Radiology 1998; 209: 491–498.

    Article  PubMed  Google Scholar 

  23. Cadranel J, Gillet-Juvin K, Antoine M, Carnot F, Reynaud P, Parrot A et al. Site-directed bronchoalveolar lavage and transbronchial biopsy in HIV-infected patients with pneumonia. Am J Respir Crit Care Med 1995; 152: 1103–1106.

    Article  CAS  PubMed  Google Scholar 

  24. Boersma W, Erjavec Z, van der Werf T, de Vries-Hosper H, Gouw A, Manson W . Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL. Respir Med 2007; 101: 317–325.

    Article  PubMed  Google Scholar 

  25. Gruson D, Hilbert G, Valentino R, Vargas F, Chene G, Bebear C et al. Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates. Crit Care Med 2000; 28: 2224–2230.

    Article  CAS  PubMed  Google Scholar 

  26. Cazzadori A, Di Perri G, Todeschini G, Luzzati R, Boschiero L, Perona G et al. Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest 1995; 107: 101–106.

    Article  CAS  PubMed  Google Scholar 

  27. Luna C, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111: 676–685.

    Article  CAS  PubMed  Google Scholar 

  28. Rano A, Agusti C, Jimenez P, Angrill J, Benito N, Danes C et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax 2001; 56: 379–387.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Kollef M, Sherman G, Ward S, Fraser VJ . Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462–474.

    Article  CAS  PubMed  Google Scholar 

  30. Afessa B, Tefferi A, Litzow MR, Krowka MJ, Wylam ME, Peters SG . Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002; 166: 641–645.

    Article  PubMed  Google Scholar 

  31. Lewis ID, DeFor T, Weisdorf DJ . Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy. Bone Marrow Transplant 2000; 26: 539–543.

    Article  CAS  PubMed  Google Scholar 

  32. Gupta S, Jain A, Warneke C, Gupta A, Shannon V, Morice R et al. Outcome of alveolar hemorrhage in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2007; 40: 71–78.

    Article  CAS  PubMed  Google Scholar 

  33. Epstein C, Elidemir O, Colasurdo GN, Fan LL . Time course of hemosiderin production by alveolar macrophages in a murine model. Chest 2001; 120: 2013–2020.

    Article  CAS  PubMed  Google Scholar 

  34. Sherman J, Winnie G, Thomassen MJ, Abdul-Kari FW, Boat TF . Time course of hemosiderin production and clearance by human pulmonary macrophages. Chest 1984; 86: 409–411.

    Article  CAS  PubMed  Google Scholar 

  35. Cordasco EM, Mehta AC, Ahmad M . Bronchoscopically induced bleeding: a summary of nine year's Cleveland Clinic experiences and review of the literature. Chest 1991; 100: 1141–1147.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

DPK has received research support and honoraria from Schering-Plough, Pfizer, Astellas Pharma Inc., Enzon Pharmaceuticals and Merck and Co. Inc. The study did not receive any financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V R Shannon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shannon, V., Andersson, B., Lei, X. et al. Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant 45, 647–655 (2010). https://doi.org/10.1038/bmt.2009.203

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.203

Keywords

This article is cited by

Search

Quick links